Enantioselective Synthesis of PPAR (Peroxisome Proliferator-Activated Receptors) Agonists and Antagonists

被引：1
|
作者：
Goya, Pilar [1 ]
Perez-Fernandez, Ruth [1 ]
Gonzalez-Muniz, Rosario [1 ]
Elguero, Jose [1 ]
机构：
[1] CSIC, Inst Quim Med, E-28006 Madrid, Spain
来源：
CURRENT TOPICS IN MEDICINAL CHEMISTRY | 2014年 / 14卷 / 10期
关键词：
PPAR; enantioselective separation; enantioselective synthesis; Evans' chiral auxiliary; asymmetric hydrogenation; chiral HPLC; chiral salts; PHENYLPROPANOIC ACID-DERIVATIVES; EFFICIENT ASYMMETRIC-SYNTHESIS; ALPHA/GAMMA DUAL AGONISTS; LIGAND-BINDING DOMAIN; BIOLOGICAL EVALUATION; ALPHA AGONIST; DESIGN; POTENCY; AGENTS;
D O I：
10.2174/1568026614666140423112822
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
This review deals with stereoselective issues in PPAR ligands some of which are in clinical use for treating certain metabolic disorders. After a short introduction of these nuclear receptor and their agonists, some cases of enantioselective separations are reported. The main part concerns stereoselective synthesis first starting with asymmetric synthesis from chiral precursors followed by what we refer to as "true" enantioselective methods. Some examples are discussed in detail for each particular heading.
引用
收藏
页码：1283 / 1293
页数：11
相关论文
共 50 条
  • [31] Hydroxy Monounsaturated Fatty Acids as Agonists for Peroxisome Proliferator-Activated Receptors
    Yokoi, Hiroshi
    Mizukami, Hajime
    Nagatsu, Akito
    Tanabe, Hiroki
    Inoue, Makoto
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2010, 33 (05) : 854 - 861
  • [32] Expression of peroxisome proliferator-activated receptor (PPAR)γ in gastric cancer and inhibitory effects of PPARγ agonists
    H Sato
    S Ishihara
    K Kawashima
    N Moriyama
    H Suetsugu
    H Kazumori
    T Okuyama
    M A K Rumi
    R Fukuda
    N Nagasue
    Y Kinoshita
    British Journal of Cancer, 2000, 83 : 1394 - 1400
  • [33] PPARs (Peroxisome Proliferator-activated Receptors) and Their Agonists in Alzheimer's Disease
    Kumar, Mohit
    Ashok, Sharma Anita
    Datusalia, Ashok Kumar
    Khatik, Gopal L.
    MEDICINAL CHEMISTRY, 2024, 20 (08) : 781 - 798
  • [34] Peroxisome proliferator-activated receptor γ (PPARγ) and sepsis
    von Knethen, Andreas
    Soller, Mathias
    Bruene, Bernhard
    ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS, 2007, 55 (01) : 19 - 25
  • [35] Peroxisome proliferator-activated receptor γ (PPARγ) and sepsis
    Andreas von Knethen
    Mathias Soller
    Bernhard Brüne
    Archivum Immunologiae et Therapiae Experimentalis, 2007, 55 : 19 - 25
  • [36] Peroxisome proliferator-activated receptor δ (PPARδ) in psoriasis
    Westergaard, M
    Henningsen, J
    Johansen, C
    Svendsen, ML
    Iversen, L
    Bolund, L
    Kragballe, K
    Kristiansen, K
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2000, 115 (03) : 582 - 582
  • [37] Proliferating peroxisome proliferator-activated receptors
    不详
    DIABETES OBESITY & METABOLISM, 2000, 2 (05): : 332 - 333
  • [38] Peroxisome proliferator-activated receptors and inflammation
    Moraes, Leonardo A.
    Piqueras, Laura
    Bishop-Bailey, David
    PHARMACOLOGY & THERAPEUTICS, 2006, 110 (03) : 371 - 385
  • [39] Evidence for peroxisome proliferator-activated receptor (PPAR)α-independent peroxisome proliferation:: Effects of PPARγ/δ-specific agonists in PPARα-Null mice
    DeLuca, JG
    Doebber, TW
    Kelly, LJ
    Kemp, RK
    Molon-Noblot, S
    Sahoo, SP
    Ventre, J
    Wu, MS
    Peters, JM
    Gonzalez, FJ
    Moller, DE
    MOLECULAR PHARMACOLOGY, 2000, 58 (03) : 470 - 476
  • [40] Peroxisome proliferator-activated receptors and their functions
    Jiao, HL
    Ye, P
    Zhao, BL
    PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS, 2001, 28 (04) : 478 - 481
12345